BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• 

  Drug Development

  Going Up Against AbbVie’s Humira, Johnson & Johnson Presents Less-Than-Stellar Phase III Data

  November 14, 2016

   · 

  2 min read
• Drug Development

  Braeburn Pharma And Camurus Announce Positive Top-Line Phase 3 Results For Long-Acting Buprenorphine (CAM2038) For Treatment Of Opioid Addiction

  November 14, 2016

   · 

  13 min read
• BioMidwest

  Eight Weeks Of Treatment With AbbVie’s Investigational, Pan-Genotypic Regimen Of Glecaprevir/Pibrentasvir (G/P) Achieved High SVR Rates Across All Major Genotypes Of Chronic Hepatitis C

  November 14, 2016

   · 

  7 min read
• Genetown

  American Association for Study of Liver Diseases Release: New Genetics Study Shows Fatty Liver Disease Cirrhosis Could Run In Families

  November 14, 2016

   · 

  4 min read
• Genetown

  American Association for Study of Liver Diseases Release: Large Study Identifies Increase Of Cirrhosis In Hepatitis C Patients

  November 14, 2016

   · 

  4 min read
• Drug Development

  Eiger Biopharma Announces Positive Phase 2 Data At The American Association for Study of Liver Diseases Meeting: Multiple Paths Forward Identified With Lonafarnib Therapy In LOWR HDV Program

  November 14, 2016

   · 

  11 min read
• BioMidwest

  Recombinetics Closes $10 Million Stock Offering

  November 14, 2016

   · 

  2 min read
• Business

  Integrity Applications Incorporated Release: GlucoTrack Maker Names Two New Board Members

  November 14, 2016

   · 

  5 min read
• FDA

  FDA Clears CapsoVision’s CapsoCam Plus

  November 14, 2016

   · 

  3 min read
• Drug Development

  Eli Lilly Release: Baricitinib Demonstrates Early Response Compared To Placebo And Significant Improvement Compared To Adalimumab In Patient-Reported Outcomes

  November 14, 2016

   · 

  9 min read